A medical device company focused on improving vascular health for patients with dialysis access challenges and Peripheral Artery Disease, Solaris Endovascular has secured $5.0M in new funding. The US-based firm, known for its advanced endovascular solutions, received the capital from UTVentures.
Solaris Endovascular leverages a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech. The company is committed to transforming vascular health and improving long-term patient outcomes.
















